Chemical Structure (Levofloxacin 01)
Levofloxacin
Product Images NDC 0409-0528
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0409-0528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Levofloxacin 02)
Figure 3 (Levofloxacin 03)
This is a graph showing the time profiles of the mean levofloxacin plasma concentration after taking a 500mg tablet orally and 500mg intravenously. The y-axis shows the plasma concentration in mcg/mL.*
Logo (Levofloxacin 04)
Logo (Levofloxacin 05)
Principal Display Panel (50 mL Bag Label)
Principal Display Panel (50 mL Bag Pouch)
Levofloxacin in 5% Dextrose Injection is a medication used for intravenous infusion with a concentration of 250 mg in 50 mL 5% Dextrose, equivalent to 5 mg/mL. It is important to leave the bag in the overwrap until use and store it at room temperature. It contains a hydrochloric acid, NF and/or sodium hydroxide, NF for pH adjustment. It should not be used in an ongoing connection and any unused portion should be discarded. It is available in a single unit, with product information including dosage and storage instructions.*
Principal Display Panel (100 mL Bag Label)
Levofloxacin in 5% Dextrose Injection is a single-use, nonpyrogenic container with 500 mg of levofloxacin diluted in 100 mL of 5% dextrose. It is used for intravenous infusion and must be used immediately after opening. The infusion should take 60 minutes, and no further dilution is necessary. The container should not be used in series connection or with additives infused with the same IV line. The container closure does not contain natural rubber latex. It is distributed by Hospira and contains DEHP.*
Principal Display Panel (100 mL Bag Pouch)
This is a label for Levofloxacin in 5% Dextrose Injection, which is a solution for intravenous infusion administered over 60 minutes. Each 100 mL contains a dilution solution equivalent to 500mg of Levofloxacin, along with 5% Dextrose. The dosage, storage instructions, and handling precautions are mentioned. There is also an indication that the bag should be left in the overwrap until used and that the single-use container should be discarded after use. The label also mentions the NDC number and manufacturer's information.*
Principal Display Panel (150 mL Bag Label)
This is a description of a medication called Levofloxacin in 5% Dextrose Injection which comes in a 150 mL container with 750 mg of the medication per 150 mL. The medication is meant to be used for intravenous infusion without further dilution. The container should be used immediately upon removal from the overwrap and should not be used in series connection. Any unused portion should be discarded after use. The medication is sterile and non-pyrogenic and should only be used if the solution is clear and the container is undamaged. The usual adult dosage is not provided in the text. The medication is distributed by Hospira, Inc. in Lake Forest, USA. The expiration date is also provided.*
Principal Display Panel (150 mL Bag Pouch)
Levofloxacin in 5% dextrose injection is a dilute solution used for intravenous infusion with a total volume of 150 mL. Its usual adult dosage is advised to be checked before use. The product must be stored at 20 to 26°C (68 to 77°F) and should not be frozen. It is a single-use container, and any unused portion should be discarded. The container does not contain natural rubber latex, and additives must not be added to the same intravenous line. It is distributed by Hospira, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
